The history of angiogenesis inhibitors-Reference-Cited by-同舟云学术

The history of angiogenesis inhibitors

Published:2007-07-18 Issue:8 Volume:21 Page:1606-1609
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Ribatti D

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2404756.pdf

Reference53 articles.

1. Folkman J . Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182–1186.

2. Strander H . Interferon treatment of human neoplasia. Adv Cancer Res 1986; 46: 1–265.

3. Brouty-Boye D, Zetter BR . Inhibition of cell motility by interferon. Science 1980; 208: 16–18.

4. Sidky YA, Borden EC . Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res 1987; 47: 5155–5161.

5. Dvorak HF, Gresser I . Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice. J Natl Cancer Inst 1989; 81: 497–502.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant human endostatin as a potential anti-angiogenic agent: therapeutic perspective and current status;Medical Oncology;2023-12-21

2. Therapeutic hydrogel for enhanced immunotherapy: A powerful combination of MnO2 nanosheets and vascular disruption;Nano Today;2022-12

3. The past, present, and future of chemotherapy with a focus on individualization of drug dosing;Journal of Controlled Release;2022-12

4. Review and comparative analysis of machine learning-based predictors for predicting and analyzing of anti-angiogenic peptides;Current Medicinal Chemistry;2021-08-10

5. GT198 Is a Target of Oncology Drugs and Anticancer Herbs;Frontiers in Oral Health;2021-06-11